Search or

𝛼SK

ENTITY

SillaJen Inc (215600 KS)

52

Analysis

Health Care • South Korea

SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.

more

Refresh

Exchange Announcement • 20 Oct 2025 17:17

Organization of Investor Relations Event

Exchange Announcement • 10 Oct 2025 14:34

Material Management Information related to Judgment of Investment(Approval for IND Modification)(ì§íì± ê³ íì ëë ì¬ë°ì±/ë¶ìì± ê¸ì± ê³¨ìì± ë°±íë³ íìë¥¼ ëìì¼ë¡ BAL0891ì ë¨ì¼ìë² ë° íìííìë² ëë í°ì¤ë ë¦¬ì£¼ë§ê³¼ì ë³ì©ìë²ì ëí ë¯¸êµ FDA ì 1ì ìììí ê³í(IND) ë³ê²½ ì¹ì¸)

Exchange Announcement • 23 Sep 2025 17:20

[Revised] Material Management Information related to Judgment of Investment(Approval for IND Modification)(ì§íì± ê³ íì ëë ì¬ë°ì±/ë¶ìì± ê¸ì± ê³¨ìì± ë°±íë³ íìë¥¼ ëìì¼ë¡ BAL0891ì ë¨ì¼ìë² ë° íìííìë² ëë í°ì¤ë ë¦¬ì£¼ë§ê³¼ì ë³ì©ìë²ì ëí ìíìì½íìì ì² ì 1ì ìììí ê³í ë³ê²½ ì¹ì¸)

Exchange Announcement • 09 Sep 2025 16:07

Material Management Information related to Judgment of Investment(Approval for IND Modification)(ì§íì± ê³ íì ëë ì¬ë°ì±/ë¶ìì± ê¸ì± ê³¨ìì± ë°±íë³ íìë¥¼ ëìì¼ë¡ BAL0891ì ë¨ì¼ìë² ë° íìííìë² ë° í°ì¤ë ë¦¬ì£¼ë§ê³¼ì ë³ì©ìë²ì ëí ìíìì½íìì ì² ì 1ì ìììí ê³í ë³ê²½ ì¹ì¸)

Exchange Announcement • 05 Aug 2025 18:38

Designation as Violator of Disclosure Regulations(ê³µìë³ê²½)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x